& Meng, E
/Included in US product label/ NIH
These include eczema, dermatitis (contact, atopic, seborrheic, nummular), tinea, lichen planus, lichen simplex, pityriasis rosea, cutaneous lupus erythematosus, syphilis, drug reactions, squamous cell carcinoma in situ, and mycosis fungoides (cutaneous T-cell lymphoma) (Armstrong 2014
Biochim Biophys Acta Mol basis Dis
Is Oral BPC-157 Right for You
A 30-year-old likely has far fewer senescent cells than a 60-year-old, which means: Younger individuals may notice less from FOXO4-DRI simply because there are fewer target cells to clear Older individuals or those with conditions associated with accelerated senescence (chronic inflammation, metabolic syndrome, prior chemotherapy) may have more to gain and more pronounced initial side effects from a larger clearance event Overall Health and Immune Function The immune system must clear apoptotic cells after FOXO4-DRI triggers their death